DETERMINATION OF DOSE-DEPENDENT ABSORPTION OF AMOXICILLIN FROM URINARY-EXCRETION DATA IN HEALTHY-SUBJECTS

被引:23
|
作者
CHULAVATNATOL, S [1 ]
CHARLES, BG [1 ]
机构
[1] UNIV QUEENSLAND,DEPT PHARM,BRISBANE,QLD 4072,AUSTRALIA
关键词
AMOXICILLIN; DOSE-DEPENDENT; ABSORPTION; MICHAELIS-MENTEN; PHARMACOKINETICS;
D O I
10.1111/j.1365-2125.1994.tb04353.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Measurement of unchanged drug in urine was used to study the rate and extent of amoxycillin absorption after administration of amoxycillin sodium solution to six healthy subjects in a Latin-Square crossover design. The mean (95% CI) fraction of the dose excreted as unchanged amoxycillin decreased (P < 0.05) from 0.50 (0.44-0.56) after 97 mg amoxycillin sodium (= 0.25 mmol amoxycillin) to 0.23 (0.19-0.27) after 3103 mg (8 mmol), while the mean residence time determined from urinary excretion rate data increased (P < 0.05) from 1.54 (1.32-1.76) h to 2.16 (2.01-2.41) h. Plots of total urinary excretion and initial (0-30 min) excretion of unchanged drug vs dose indicated significant non-linearity above 776 mg doses. Michaelis-Menten parameters describing this relationship with respect to amount absorbed were 3.02 mmol for maximum amount absorbed and 1.93 mmol for amount absorbed at half maximum for 0-30 min. These results support a saturable absorption mechanism for amoxycillin which has clinical implications for high oral amoxycillin doses, and for competition with other drugs having capacity-limited absorption.
引用
收藏
页码:274 / 277
页数:4
相关论文
共 22 条
  • [1] DOSE-DEPENDENT ABSORPTION OF AMOXICILLIN IN PATIENTS WITH AN ILEOSTOMY
    SJOVALL, J
    ALVAN, G
    AKERLUND, JE
    SVENSSON, JO
    PAINTAUD, G
    NORD, CE
    ANGELIN, B
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (03) : 277 - 281
  • [2] Dose-dependent absorption, metabolism, and excretion of genistein in rats
    Zhou, Siyuan
    Hu, Yuzhen
    Zhang, Bangle
    Teng, Zenghui
    Gan, Hongquan
    Yang, Zhifu
    Wang, Qingwei
    Huan, Menglei
    Mei, Qibing
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2008, 56 (18) : 8354 - 8359
  • [3] Dose-Dependent Flux of Buprenorphine Following Transdermal Administration in Healthy Subjects
    Wang, Yi
    Cipriano, Alessandra
    Munera, Catherine
    Harris, Stephen C.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (10) : 1263 - 1271
  • [4] PHARMACOKINETICS AND URINARY ELECTROLYTE EXCRETION EFFECTS OF ORAL FRUSEMIDE AND FRUSEMIDE-AMILORIDE COMBINATION TABLETS IN HEALTHY-SUBJECTS
    KANTELIP, JP
    AIACHE, JM
    BEYSSAC, E
    ABELLA, ML
    THERAPIE, 1991, 46 (06): : 475 - 479
  • [5] DOSE-DEPENDENT ABSORPTION AND ELIMINATION OF GAMMA-HYDROXYBUTYRIC ACID IN HEALTHY-VOLUNTEERS
    PALATINI, P
    TEDESCHI, L
    FRISON, G
    PADRINI, R
    ZORDAN, R
    ORLANDO, R
    GALLIMBERTI, L
    GESSA, GL
    FERRARA, SD
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 (04) : 353 - 356
  • [6] Dose-Dependent Acute and Sustained Renal Effects of the Endothelin Receptor Antagonist Avosentan in Healthy Subjects
    Smolander, J.
    Vogt, B.
    Maillard, M.
    Zweiacker, C.
    Littke, T.
    Hengelage, T.
    Burnier, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (06) : 628 - 634
  • [7] DOSE-DEPENDENT INTESTINAL-ABSORPTION AND SIGNIFICANT INTESTINAL EXCRETION (EXSORPTION) OF THE BETA-BLOCKER PAFENOLOL IN THE RAT
    LENNERNAS, H
    REGARDH, CG
    PHARMACEUTICAL RESEARCH, 1993, 10 (05) : 727 - 731
  • [8] Absorption, Metabolism, and Excretion of Darunavir, a New Protease Inhibitor, Administered Alone and with Low-Dose Ritonavir in Healthy Subjects
    Vermeir, Marc
    Lachau-Durand, Sophie
    Mannens, Geert
    Cuyckens, Filip
    van Hoof, Bart
    Raoof, Araz
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (04) : 809 - 820
  • [9] Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
    Seman, Leo
    Macha, Sreeraj
    Nehmiz, Gerhard
    Simons, Gudrun
    Ren, Bailuo
    Pinnetti, Sabine
    Woerle, Hans J.
    Dugi, Klaus
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (02): : 152 - 161
  • [10] RELATIVE BIOAVAILABILITY OF CARBINOXAMINE AND PHENYLEPHRINE FROM A RETARD CAPSULE AFTER SINGLE AND REPEATED DOSE ADMINISTRATION IN HEALTHY-SUBJECTS
    STOCKIS, A
    DEROUBAIX, X
    JEANBAPTISTE, B
    LINS, R
    ALLEMON, AM
    LAUFEN, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-2 (09): : 1009 - 1012